ImmunityBio Stock (IBRX)

Track ImmunityBio stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.

$7.05

▲ +4.02 (+127.62%) past year

Live · Updated Jun 9, 4:37 PM

Market Cap

$7.51B

P/E Ratio

—

1Y Return

+127.62%

EPS (TTM)

-$0.85

Read the latest TheStreet Pro articles mentioning ImmunityBio, including market roundups, portfolio updates, trade ideas, and investing analysis.

Articles

3 articles

trade-ideas I'm Patiently Building Positions in These Stocks Amid Market's Chaos
James "Rev Shark" DePorreMar 11, 2026
IBRX MAGS ORCL
trade-ideas Three Biotechs With the Right Formula
Bret JensenFeb 25, 2026
IBRX VIR IOVA
trade-ideas Two Biotechs to Play in Uncertain Times
Bret JensenJan 16, 2026
IBRX C BAC

Daily Diary Mentions

0 mentions

No diary mentions for IBRX yet.